Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
Schiffner
R
R
Department of Dermatology, University of Regensburg, Germany.
Glässl
A
A
Landthaler
M
M
Stolz
W
W
D000925:Anticoagulants / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004485:Eczema / Q000139:chemically induced; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000276:immunology; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006496:Heparinoids / Q000009:adverse effects*; D024764:Hirudin Therapy; D006629:Hirudins / Q000031:analogs & derivatives*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis / Q000209:etiology; D007275:Injections, Intravenous; D007428:Intradermal Tests; D008875:Middle Aged; D010328:Patch Tests; D011994:Recombinant Proteins / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin; C060225:desirudin